Health News
Your DNA Plays Greater Role in Heart Attack
A predisposition for heart attack risk is defined by genetics. Doesn't that mean the risks for heart diseases are the same? In fact, one particular risk seems to lead the way.
Seaweed is Always Greener Under the Sea
The slimy, icky gooey stuff floating in the ocean, more commonly known as seaweed, is a delicacy in some countries and even provides heart health benefits.
Sudden Heart Attack Predictors Identified
Researchers have long pondered whether it might be possible to predict the likelihood that someone will survive a heart attack. Certain traits may be good predictors.
Preventing Heart Disease Delivers a ROI
Cardiovascular disease comes with a hefty price tag. Empowering each individual to take action preventing heart disease is a better long-term investment for health, according to a recent statement by the American Heart Association.
Diabetes Test for Your Heart
If you have diabetes, it is important to keep track of your blood sugar levels. The A1C test is the best measure of blood sugar, but it may also let you know about risks to your heart health.
Label Warnings Updated for Chantix
U.S. Food and Drug Administration (FDA) officials have approved an updated drug label for smoking cessation medication varenicline (Chantix) with stronger warnings.
Optimism Linked to Lower Stroke Risk
There's something to be said for patients brimming with optimism. A positive outlook may actually improve your health. Those with a sunny outlook may be at a reduced risk of stroke.
FDA Drug Safety Communication: Letairis
The U.S. Food and Drug Administration (FDA) is removing the warning related to liver injury from the boxed warning of the Letairis ( ambrisentan ) tablet label.
FDA Drug Safety Communication: Pradaxa
The U.S. Food and Drug Administration (FDA) is alerting the public to important storage and handling requirements for Pradaxa ( dabigatran etexilate mesylate ) capsules.
FDA Drug Safety Communication: Benicar
After reviewing the results of the ROADMAP and ORIENT trials, the FDA has determined that the benefits of Benicar continue to outweigh its potential risks when used for the treatment of patients with high blood pressure according to the drug label. Benicar is not recommended as a treatment to delay or prevent protein in the urine ( microalbuminuria ) in diabetic patients.
Patients should consult their healthcare professional if they have any questions or concerns about taking Benicar .
Daiichi Sankyo , the makers of Benicar , have agreed to work with the FDA to perform additional ...